Islamabad, Feb 27: Citi Pharma Limited (PSX: CPHL) has marked a significant milestone by completing its first export order to the Middle East and North Africa (MENA) region. This achievement follows the company’s recent FDA accreditation on September 20, 2024, which opened doors to international markets.
The export deal, valued at €560,000, was finalized with an initial advance payment of €200,000, while the remaining €360,000 has now been received. This successful transaction demonstrates Citi Pharma’s growing presence in the global pharmaceutical industry.
Looking ahead, Citi Pharma aims to generate between €8 million and €10 million annually in exports to the MENA region alone. The company also has similar expansion plans targeting North America and other international markets, reinforcing its strategic vision for global growth.
Read More:
Latest Gold Prices in Pakistan – 27th February 2025
Citi Pharma Limited specializes in the manufacturing and distribution of pharmaceuticals, medical chemicals, and botanical products. With this export breakthrough, the company is set to strengthen its footprint in international markets, creating new opportunities for expansion and long-term success.
This milestone not only underscores Citi Pharma’s commitment to quality and compliance but also positions it as a key player in the pharmaceutical industry worldwide.
